Hydroxyproline excretion in the urine as a measure of anti-inflammatory effect in rheumatic patients using naproxen.
D000284:Administration, Oral; D000893:Anti-Inflammatory Agents; D002986:Clinical Trials as Topic; D003864:Depression, Chemical; D004341:Drug Evaluation; D006801:Humans; D006909:Hydroxyproline / Q000652:urine*; D008738:Methyl Ethers / Q000008:administration & dosage; D009281:Naphthalenes / Q000008:administration & dosage / Q000627:therapeutic use; D011422:Propionates / Q000008:administration & dosage / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*
D000893:Anti-Inflammatory Agents; D008738:Methyl Ethers; D009281:Naphthalenes; D011422:Propionates; D006909:Hydroxyproline